LLY

Lilly(Eli) & Co

1,373.70

Oct 29 • 3:59 PM ET +85.40 (6.63%)

1,383.29

Aftermarket • 7:59 PM ET +9.59 (0.70%)

Healthcare Drug Manufacturers - General USA Mega NYSE

Today, 1:33 PMEli Lilly beats Q3 estimates and raises 2026 outlook again as incretin franchise and Medicare GLP‑1 Bridge outperform

Peers: NVO ABBV AMGN AZN MRK JNJ BMY NVS PFE SNY

| Held by: VTI VOO IVV SPY VUG XLV VIG IWF SPYM VHT

Scroll to Statements

Index	S&P 500
Market Cap	1293.14B
Enterprise Value	1339.10B
Income	26.71B
Sales	79.67B
Book/sh	35.98
Cash/sh	9.51
Dividend Est.	6.82 (0.50%)
Dividend TTM	6.69 (0.49%)
Dividend Ex-Date	Nov 13, 2026
Dividend Gr. 3/5Y	15.24% 15.18%
Payout	26.14%
Employees	50000
IPO	Jul 09, 1970

P/E	46.68
Forward P/E	28.56
PEG	0.92
P/S	16.23
P/B	38.18
P/C	144.49
P/FCF	71.09
EV/EBITDA	32.11
EV/Sales	16.81
Quick Ratio	1.00
Current Ratio	1.35
Debt/Eq	1.62
LT Debt/Eq	1.41
Option/Short	Yes / Yes

EPS (ttm)	29.43
EPS next Y	48.09
EPS next Q	10.45
EPS this Y	41.66%
EPS next Y	40.23%
EPS next 5Y	31.14%
EPS past 3/5Y	49.25% 27.59%
Sales past 3/5Y	31.69% 21.58%
EPS Y/Y TTM	95.08%
Sales Y/Y TTM	49.58%
EPS Q/Q	26.20%
Sales Q/Q	47.67%
Earnings	Oct 29 BMO
EPS/Sales Surpr.	31.60% 8.03%

Insider Own	9.87%
Insider Trans	-0.03%
Inst Own	76.50%
Inst Trans	0.26%
ROA	21.96%
ROE	102.43%
ROIC	32.68%
Gross Margin	83.40%
Oper. Margin	49.72%
Profit Margin	33.53%
SMA20	11.48%
SMA50	15.08%
SMA200	26.08%
Trades

Shs Outstand	941.50M
Shs Float	848.41M
Short Float	0.82%
Short Ratio	2.79
Short Interest	6.96M
52W High	1321.21 3.97%
52W Low	809.63 69.67%
Volatility	3.37% 2.94%
ATR (14)	42.52
RSI (14)	74.44
Beta	0.43
Rel Volume	1.76
Avg Volume	2.49M
Volume	4,373,971

Perf Week	5.13%
Perf Month	18.72%
Perf Quarter	19.57%
Perf Half Y	46.98%
Perf YTD	27.82%
Perf Year	68.86%
Perf 3Y	145.20%
Perf 5Y	439.21%
Perf 10Y	1743.15%
Recom	1.48
Target Price	1405.49
Prev Close	1288.30
Price	1373.70
Change %	6.63%

Consensus

Strong Buy

Avg. Price Target

$1,405.49

Implied Upside

+2.3%

Analysts13incl. previous ratings

Rating Distribution12 Buy · 0 Hold · 1 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Sep 15, 2026	Upgrade	BBerenberg	Hold → Buy	$1400	+1.9%
Mar 17, 2026	Downgrade	HHSBC Securities	Hold → Reduce	$850	-38.1%
Feb 25, 2026	Initiated	RRBC Capital Mkts	Outperform	$1250	-9.0%
Feb 20, 2026	Initiated	BBarclays	Overweight	$1350	-1.7%
Jan 07, 2026	Resumed	UUBS	Buy	$1250	-9.0%
Dec 16, 2025	Upgrade	DDaiwa Securities	Neutral → Buy	$1230	-10.5%
Dec 15, 2025	Reiterated	GGoldman	Buy	$951 → $1145	-16.6%
Dec 15, 2025	Reiterated	BBofA Securities	Buy	$1286 → $1268	-7.7%
Nov 13, 2025	Initiated	BScotiabank	Sector Outperform	$1165	-15.2%
Nov 10, 2025	Upgrade	LLeerink Partners	Market Perform → Outperform	$1104	-19.6%
Oct 20, 2025	Reiterated	BBMO Capital Markets	Outperform	$840 → $930	-32.3%
Oct 14, 2025	Upgrade	EErste Group	Hold → Buy
Sep 17, 2025	Downgrade	BBerenberg	Buy → Hold	$830	-39.6%
Aug 27, 2025	Upgrade	HHSBC Securities	Reduce → Hold	$700	-49.0%
Aug 18, 2025	Downgrade	DDaiwa Securities	Outperform → Neutral	$700	-49.0%
Aug 07, 2025	Downgrade	LLeerink Partners	Outperform → Market Perform	$715	-48.0%
Jun 05, 2025	Downgrade	EErste Group	Buy → Hold
Apr 28, 2025	Downgrade	HHSBC Securities	Buy → Reduce	$1150 → $700	-49.0%
Apr 22, 2025	Initiated	CCantor Fitzgerald	Overweight	$975	-29.0%
Dec 10, 2024	Resumed	BBofA Securities	Buy	$997	-27.4%

Today 05:01PM	Earnings live updates: Sandisk posts solid earnings, announces 8-for-1 stock split (Yahoo Finance) +6.63%
04:23PM	Russell 2000 Extends Rally Despite Broader Market Selloff (Schaeffer's Research)
03:41PM	Weight-Loss Drugs Are Fueling a Beauty Boom. Two Stocks That Stand to Benefit. (Barrons.com)
03:21PM	Eli Lilly's Obesity Pill a Weak Spot in Otherwise Strong Quarter (The Wall Street Journal)
03:18PM	Eli Lilly Clears Consensus But Misses The Whisper As A $4.57 IPR&D Charge Masks A Third Straight Guidance Raise (Earnings Whispers)
01:42PM	Loading…
01:42PM	Eli Lilly lifts revenue outlook as weight-loss shot demand soars, shares jump (Reuters)
01:16PM	Earnings live updates: Eli Lilly stock pops as strong GLP-1 drug demand lifts results, ServiceNow stock plunges (Yahoo Finance)
12:46PM	Drugmakers Shrug Off Trump Pricing Pressure With Record Revenue (Bloomberg)
12:26PM	Lilly's obesity drug strength fuels record rally, Wall Street optimism (Reuters)
11:32AM	Eli Lilly shares jump 6% as drugmaker lifts 2026 revenue forecast (Proactive)
11:30AM	Novo Nordisk faces tougher GLP-1 competition, Citi says (Proactive)
11:27AM	Walmart, Eli Lilly Join 38 Companies Opposing OKX-ICE Tokenized Stocks (CryptoProwl)
11:19AM	Eli Lilly Shares Rise 4% as Q3 Earnings Exceed Estimates and Revenue Outlook Increases (InvestorsHub)
11:13AM	Healthcare sector climbs into record territory, as earnings provide a big boost (MarketWatch)
11:07AM	Walmart, Eli Lilly and Cigna File Objections to ICE and OKXs Tokenized Stock Venue (Unchained)
11:07AM	Loading…
11:07AM	Walmart Blocks Its Stock From OKX-ICE Tokenized Trading Venue (decrypt)
10:22AM	Eli Lilly CEO Dave Ricks on the obesity market: The room for expansion is dramatic (CNBC TV)
09:55AM	Eli Lilly stock jumps as drugmaker raises outlook on booming sales of diabetes and obesity treatments (Yahoo Finance)
09:53AM	Alphabet tumbles, software and cybersecurity stocks sink as earnings disappoint: AlphaCheck (Yahoo Finance)
09:39AM	GDP, PCE, Jobless Claims and Q3 Earnings - Busy Morning! (Zacks)
08:50AM	Eli Lilly Blows Past Sales Expectations And Hikes Outlook On Mounjaro, Zepbound Dominance (Investor's Business Daily)
08:24AM	Eli Lilly CEO Cites Growth Beyond Weight Loss In Oncology, Immunology As Key To FY 2026 Outlook Raise LLY Stock Surges To Record High In Pre-Market (Stocktwits)
07:26AM	Eli Lilly jumps on earnings beat, raised revenue guidance (Investing.com)
07:22AM	Eli Lilly Revenue Climbs on Demand for Mounjaro, Zepbound (The Wall Street Journal)
07:09AM	Eli Lilly Stock Jumps as Monster Earnings Powered by Mounjaro and Zepbound (Barrons.com)
07:03AM	Lilly raises outlook for third time this year as Zepbound sales soar. (MarketWatch)
06:50AM	Lilly: Q3 Earnings Snapshot (Associated Press)
06:45AM	Lilly reports third-quarter 2026 financial results, raises full-year guidance and highlights regulatory progress across the portfolio (PR Newswire)
05:35AM	Amazon headlines another busy day of earnings that includes Intel and Sandisk (MarketWatch)
04:29AM	Stock Market Today: Dow set for 300-point gain as S&P 500 and Nasdaq poised to decline after Alphabet results; Amazon and Intel earnings on tap (MarketWatch)
06:16PM	Loading…
Oct-28-26 06:16PM	Earnings live updates: ServiceNow stock plunges on Q3 earnings miss (Yahoo Finance)
05:28PM	Dow Jones Futures: Microsoft Rises Late, But Google, ServiceNow And Fortinet Dive On Earnings (Investor's Business Daily)
04:23PM	Earnings live updates: Boeing stock falls on mixed Q3 turnaround picture, SoFi surges (Yahoo Finance)
02:23PM	Lillys retatrutide beats Ozempic in head-to-head trial (Clinical Trials Arena)
12:22PM	Zepbound grew 174.9% in 2025, the fastest rate among the top 10 drugs (Quartz)
11:53AM	Lillys triple-G drug tops Novos Ozempic in diabetes trial (BioPharma Dive)
10:21AM	After Wegovy and Zepbound, 6 weight-loss drugs in development (Quartz)
10:04AM	Eli Lilly's Next-Gen Obesity Drug Trounces Ozempic In Head-To-Head Test (Investor's Business Daily)
09:27AM	Lilly shuffles business structure; Novartis writes off part of Avidity deal (BioPharma Dive)
08:35AM	LLY Vs NVO: Lillys Retatrutide Beats Novos Ozempic In Head-To-Head Trial Retatrutide More Than Doubles Weight Loss (Stocktwits)
06:45AM	Lilly's retatrutide delivered greater A1C reduction and more than double the weight loss of Ozempic's highest approved dose in head-to-head trial (PR Newswire)
06:00AM	Heres How Much Eli Lilly Stock Is Expected to Move After Earnings (Investopedia)
Oct-27-26 04:47PM	Eli Lilly international business chief Jonsson to retire; Yuffa to head global markets unit (Reuters)
04:03PM	Patrik Jonsson to retire after 36 years; Ilya Yuffa named president, Lilly Global Markets (PR Newswire)
12:03PM	Court rejects Novo bid to block Lilly obesity drug ads (BioPharma Dive)
09:51AM	Earnings live updates: SoFi stock surges on 'exceptional' quarter, raised outlook (Yahoo Finance)
09:00AM	Moderna Has Its Doubters. CEO Bancel Plans to Answer With a Cancer Shot. (Barrons.com)
08:45AM	Healthcare Stocks Become Anti-AI Bet as Investors Turn Defensive (Bloomberg)
Oct-26-26 05:48PM	Don't Miss This Week's 5 Most Important Earnings Charts (Zacks)
04:27PM	Earnings live updates: Whirlpool stock drops on softer quarter as inflation weighs on sales (Yahoo Finance)
04:14PM	US judge won't block Eli Lilly ads for weight-loss drugs, rules against Novo Nordisk (Reuters)
03:02PM	AI Headlines Pile Up as Wall Street Navigates a Volatile Week (Zacks)
11:19AM	Lilly declares fourth-quarter 2026 dividend (PR Newswire)
10:57AM	Gilead's Latest Deal Shows Big Pharma's Appetite for Oral Peptides. Which Stocks Are Worth Watching? (FinanceWire)
Oct-25-26 10:28PM	Stocktwits Pharma Pulse: Big Pharma Earnings, Cancer Updates And 2 FDA Deadlines The Weeks Biotech Watchlist (Stocktwits)
11:27AM	What To Expect In Markets This Week: GOOGL, MSFT, AMZN, INTC, HOOD, LLY Earnings, Fed Meeting And More (Stocktwits)
Oct-24-26 07:39AM	Eli Lilly's Next-Generation Ovarian Cancer Drug Shows 79% Response Rate, 100% Disease Control In New Data (Stocktwits)
Oct-23-26 04:59PM	3 Portfolio-Worthy Stocks Hitting 52-Week Highs: AAPL, LLY & KO (Zacks)
08:34AM	Eli Lilly's Fast Growth Hasn't Slowed Its Progress As Sustainability Leader (Investor's Business Daily)
05:59AM	GLP-1 boom in China, India, Brazil could create $22 billion market by 2035, J.P. Morgan says (Reuters)
Oct-22-26 03:37PM	Investors are punishing Big Tech's biggest spenders. Meta is the latest casualty. (Yahoo Finance)
01:08PM	The Week Ahead: Wall Street Awaits October Fed Decision (Schaeffer's Research)
10:30AM	Lilly breaks ground in Richmond to expand American manufacturing of next-generation cancer medicines, advancing its build-out of 10 new U.S. sites since 2020 (PR Newswire)
Oct-21-26 04:59PM	7 healthcare stocks that stand out as investors pay up for the sector (MarketWatch)
01:25PM	Lilly's First Full Quarter Of Medicare Bridge And Foundeo Ramp Faces A Lofty Whisper (Earnings Whispers)
12:51PM	Why This Pharma Pro Likes Johnson & Johnson, Eli Lilly, and Merck Stock (Barrons.com)
10:23AM	Arcus kidney cancer data impresses analysts; TriGemX inks a SPAC deal (BioPharma Dive)
05:30AM	Healthcare Stocks Are Rallying, and Flashing a Warning for the Rest of the Market (The Wall Street Journal)
02:06AM	Beauty giants target 'Ozempic face' as boom in obesity drugs opens new market (Reuters)
Oct-20-26 06:03PM	Stephen K. Brannan, MD, and John D. Young Appointed to Slate Medicines Board of Directors (Exec Edge)
05:14PM	Dow outperforms as Wall Street rises, healthcare stocks lead gains (Reuters)
03:27PM	RBC Capital names top healthcare stocks as sector upgraded to overweight (Investing.com)
02:41PM	The Healthcare Sector Nears a New High. These Stocks Are Leading the Charge. (Barrons.com)
12:55PM	LLY Stock Hits New Record, Eli Lilly Valuation Pushes Past Berkshire Hathaway Ahead Of Q3 Earnings (Stocktwits)
Oct-19-26 02:27PM	Eli Lilly, IBD Stock Of The Day, Rides Foundayo, Medicare Bridge To Buy Point (Investor's Business Daily)
07:50AM	Lillys Omvoh leads to 50% clinical remission rate in paediatric UC (Clinical Trials Arena)
04:40AM	Lilly's Omvoh (mirikizumab-mrkz) meets primary endpoint of clinical remission and is the first IL-23p19 inhibitor to report one-year Phase 3 results in pediatric ulcerative colitis (PR Newswire)
Oct-18-26 06:05PM	Lilly to showcase advances across its oncology pipeline at the 2026 European Society for Medical Oncology (ESMO) Congress (PR Newswire)
09:30AM	European Union Regulators Recommend Approval For Eli Lilly Weight Loss Pill (TIKR)
Oct-17-26 10:45AM	The EUs Drug Regulator Backed Eli Lillys Weight-Loss Pill. Heres What Foundayo Has to Show on October 29 (TIKR)
Oct-16-26 10:57PM	What Was Eli Lilly Telling You Before Its Stock Ran? (Trefis)
03:36PM	Moderna and Novavax Stocks Slump as Biotech's Rally Takes a Breather (Barrons.com)
11:41AM	Lillys Foundayo Pill Gets European Regulatory Backing LLY Stock Heads For Best Week In Nearly Four Months (Stocktwits)
11:29AM	Lillys Foundayo wins EMA panel backing for obesity and type 2 diabetes (Pharmaceutical Technology)
07:37AM	Factbox-Weight-loss drug developers line up to tap lucrative market as competition heats up (Reuters)
Oct-15-26 04:14PM	S&P 500 ends higher as traders shift from AI to healthcare (Reuters)
03:46PM	How Has Merck's Story Changed? (Trefis)
02:25PM	Big pharma stocks near all-time highs as tech selloff pushes investors toward safer bets (MarketWatch)
10:00AM	Lilly confirms date and conference call for third-quarter 2026 financial results announcement (PR Newswire)
09:09AM	Where Could Johnson & Johnson's Next Growth Come From? (Trefis)
08:00AM	New composite outcomes data show patients treated with Lilly's Omvoh (mirikizumab-mrkz) achieved comprehensive corticosteroid-free disease control in ulcerative colitis and corticosteroid-free deep remission in Crohn's disease at one year (PR Newswire)
Oct-14-26 10:02PM	Why Eli Lilly Became Wall Streets Safe Haven on a Hot CPI Day (TIKR)
09:47PM	How Much Downside Is Left In Liquidia Stock? (Trefis)
01:39PM	Nasdaq Sheds 1.65% as Russell 2000 Sinks to RSI 28, Oil Climbs While Gold and Silver Slide (PR Newswire)
01:33PM	Lilly, Merck, AbbVie Stocks Surge. Why Healthcare Is Rallying Today. (Barrons.com)
11:13AM	Tech stocks take a back seat as healthcare names steal the show (MarketWatch)
08:53AM	Vikings Key Obesity Pill Enters Phase 3 Trial Heres What Investors Need To Know (Stocktwits)
08:18AM	The Open Question Under Johnson & Johnson Stock's Price (Trefis)
04:07AM	Cancer Drug Spending Is Headed Past $400 Billion as Colorectal and Pancreatic Cancers Move Up the Research Agenda (PR Newswire)
Oct-13-26 03:24PM	What Is Eli Lilly Stock's Biggest Opportunity? (Trefis)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
LILLY ENDOWMENT, INC.	Shareholder	Oct 15 '26	Proposed Sale	1208.74	305,000	368,665,700		Oct 15 02:44 PM
LILLY ENDOWMENT, INC.	Shareholder	Oct 07 '26	Proposed Sale	1157.49	300,000	347,247,000		Oct 07 03:24 PM
Jonsson Patrik	EVP & President, LLY Int'l	Aug 17 '26	Sale	1175.10	6,500	7,638,150	54,147	Aug 18 04:20 PM
Patrik Jonsson	Officer	Aug 17 '26	Proposed Sale	1175.10	6,500	7,638,150		Aug 17 05:06 PM
Zakrowski Donald A	SVP, Finance, & CAO	Aug 10 '26	Sale	1185.01	2,000	2,370,020	1,526	Aug 11 04:31 PM
DONALD ZAKROWSKI	Officer	Aug 10 '26	Proposed Sale	1185.71	2,000	2,371,420		Aug 10 04:31 PM
Hakim Anat	EVP, GC & Secretary	Aug 07 '26	Sale	1190.00	5,000	5,950,000	11,875	Aug 10 04:19 PM
Hakim Anat	Officer	Aug 07 '26	Proposed Sale	1190.00	10,000	11,900,000		Aug 07 10:30 AM
Seymour Melissa	EVP, Global Quality	Aug 01 '26	Option Exercise	0.00	981	0	1,506	Aug 03 04:42 PM
LILLY ENDOWMENT, INC.	Shareholder	Jul 07 '26	Proposed Sale	1200.06	310,000	372,018,600		Jul 07 03:02 PM
LILLY ENDOWMENT, INC.	Shareholder	Jun 26 '26	Proposed Sale	1127.69	305,000	343,945,450		Jun 26 01:40 PM
Yuffa Ilya	EVP&Pres, LLY USA&Global Capab	Jun 10 '26	Sale	1150.77	2,500	2,876,925	29,804	Jun 11 04:23 PM
Yuffa Ilya	Officer	Jun 10 '26	Proposed Sale	1150.77	2,500	2,876,925		Jun 10 11:03 AM
LILLY ENDOWMENT, INC.	Shareholder	May 28 '26	Proposed Sale	1082.92	310,000	335,705,200		May 28 03:02 PM
LILLY ENDOWMENT, INC.	Shareholder	May 22 '26	Proposed Sale	1041.65	300,000	312,495,000		May 22 02:05 PM
LILLY ENDOWMENT, INC.	Shareholder	May 20 '26	Proposed Sale	1021.41	305,000	311,530,050		May 20 04:22 PM
LILLY ENDOWMENT INC	Former 10% Shareholder	May 06 '26	Sale	995.36	15,828	15,754,537	91,881,150	May 07 04:00 PM
LILLY ENDOWMENT, INC.	Shareholder	May 06 '26	Proposed Sale	988.87	300,000	296,661,000		May 06 04:35 PM
Zakrowski Donald A	SVP, Finance, & CAO	Feb 16 '26	Option Exercise	0.00	184	0	3,607	Feb 18 04:22 PM
Montarce Lucas	EVP & CFO	Feb 16 '26	Option Exercise	0.00	368	0	16,418	Feb 18 04:21 PM
Custer Kenneth L.	EVP & President, Card Met Hlth	Feb 16 '26	Option Exercise	0.00	207	0	10,232	Feb 18 04:21 PM
Brown Adrienne S	EVP, President LLY Imm	Feb 16 '26	Option Exercise	0.00	391	0	5,312	Feb 18 04:19 PM
Yuffa Ilya	EVP&Pres, LLY USA&Global Capab	Feb 01 '26	Option Exercise	0.00	3,394	0	29,654	Feb 03 04:32 PM
Skovronsky Daniel	EVP, CS&PO & Pres. LRL	Feb 01 '26	Option Exercise	0.00	12,684	0	150,165	Feb 03 04:31 PM
Van Naarden Jacob	EVP,Pres LLY Oncology&HdCorpBD	Feb 01 '26	Option Exercise	0.00	4,108	0	24,670	Feb 03 04:31 PM
Ricks David A	President, Chair, and CEO	Feb 01 '26	Option Exercise	0.00	31,932	0	547,098	Feb 03 04:29 PM
Rau Diogo	EVP & CIDO	Feb 01 '26	Option Exercise	0.00	3,752	0	23,471	Feb 03 04:28 PM
Jonsson Patrik	EVP & President, LLY Int'l	Feb 01 '26	Option Exercise	0.00	3,930	0	57,581	Feb 03 04:27 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Feb 01 '26	Option Exercise	0.00	3,572	0	43,303	Feb 03 04:26 PM
Hakim Anat	EVP, GC & Secretary	Feb 01 '26	Option Exercise	0.00	6,700	0	17,662	Feb 03 04:25 PM
Dozier Eric	EVP, Chief People Officer	Feb 01 '26	Option Exercise	0.00	2,858	0	12,697	Feb 03 04:24 PM
LILLY ENDOWMENT INC	10% Owner	Jan 07 '26	Sale	1103.48	292,148	322,380,730	91,896,978	Jan 08 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jan 05 '26	Sale	1085.01	1,390	1,508,165	92,189,126	Jan 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Dec 29 '25	Sale	1085.04	3,593	3,898,531	92,190,516	Dec 30 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Dec 24 '25	Sale	1085.17	2,629	2,852,920	92,194,109	Dec 29 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Dec 23 '25	Sale	1085.04	240	260,409	92,196,738	Dec 29 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Dec 23 '25	Proposed Sale	1076.48	300,000	322,944,000		Dec 23 12:52 PM
LILLY ENDOWMENT INC	10% Owner	Nov 25 '25	Sale	1109.30	15,632	17,340,625	92,196,978	Nov 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 25 '25	Sale	1095.35	147,061	161,082,640	92,212,610	Nov 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 24 '25	Sale	1068.52	142,307	152,058,091	92,359,671	Nov 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 21 '25	Sale	1058.66	105,326	111,504,098	92,501,978	Nov 24 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 24 '25	Proposed Sale	1059.70	305,000	323,208,500		Nov 24 03:01 PM
LILLY ENDOWMENT INC	10% Owner	Nov 20 '25	Sale	1051.66	37,148	39,067,117	92,607,304	Nov 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 19 '25	Sale	1051.17	167,526	176,098,702	92,644,452	Nov 20 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 18 '25	Sale	1034.78	60,213	62,306,969	92,811,978	Nov 19 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 19 '25	Proposed Sale	1030.05	310,000	319,315,500		Nov 19 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Nov 17 '25	Sale	1030.68	9,886	10,189,269	92,872,191	Nov 18 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 14 '25	Sale	1030.87	178,295	183,799,044	92,882,077	Nov 17 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 13 '25	Sale	1030.26	46,606	48,016,098	93,060,372	Nov 14 04:00 PM
Zakrowski Donald A	SVP, Finance, & CAO	Nov 13 '25	Sale	1010.50	1,000	1,010,500	2,840	Nov 13 04:14 PM
LILLY ENDOWMENT INC	10% Owner	Nov 12 '25	Sale	1011.18	305,000	308,411,204	93,106,978	Nov 13 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 13 '25	Proposed Sale	1017.78	295,000	300,245,100		Nov 13 03:02 PM
LILLY ENDOWMENT INC	10% Owner	Nov 11 '25	Sale	986.64	283,131	279,347,680	93,411,978	Nov 12 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 10 '25	Sale	972.52	16,869	16,405,396	93,695,109	Nov 12 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 12 '25	Proposed Sale	988.62	305,000	301,529,100		Nov 12 03:15 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 10 '25	Proposed Sale	924.37	300,000	277,311,000		Nov 10 03:11 PM
LILLY ENDOWMENT INC	10% Owner	Nov 05 '25	Sale	951.56	40,432	38,473,442	93,711,978	Nov 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 05 '25	Sale	933.26	179,042	167,092,104	93,752,410	Nov 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 04 '25	Sale	910.72	526	479,038	93,931,452	Nov 05 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 03 '25	Sale	888.83	300,000	266,648,921	93,931,978	Nov 04 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 04 '25	Proposed Sale	896.53	220,000	197,236,600		Nov 04 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Oct 31 '25	Sale	863.35	301,342	260,165,031	94,231,978	Nov 03 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 03 '25	Proposed Sale	862.86	300,000	258,858,000		Nov 03 03:06 PM

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

ChairmanMr. David A. Ricks

Executive VP & CFOMr. Lucas E. Montarce

Ph.D.Dr. Daniel M. Skovronsky M.D.

Executive VPMs. Anat Hakim J.D.

Executive VPMr. Jacob S. Van Naarden

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LLY

Lilly(Eli) & Co

Upgrade your Finviz experience